Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 5, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 14, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 30, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 12, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 30, 2023
[ 12:00 AM ] - WOPRAI
Thu, March 23, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 22, 2023
[ 12:00 AM ] - WOPRAI
Thu, March 9, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 1, 2023
[ 12:00 AM ] - WOPRAI
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
Wed, December 7, 2022
[ 12:00 AM ] - WOPRAI
Fri, November 11, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 9, 2022
[ 12:00 AM ] - WOPRAI
Fri, September 23, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 11, 2022
[ 12:00 AM ] - WOPRAI
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
Tue, August 24, 2021
[ 12:00 AM ] - WOPRAI
Tue, August 17, 2021
Geulah Livshits Maintained (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024
Geulah Livshits of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024.
Geulah has made no other calls on TSHA in the last 4 months.
There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Geulah's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Geulah
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $6 on, Monday, August 12th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $7 on, Monday, July 1st, 2024
- Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $5 on, Thursday, June 27th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Thursday, June 20th, 2024
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Thursday, June 20th, 2024
- Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
Contributing Sources